How Private Equity Is Buying Up Veterinary Diagnostic Labs

Episode 63 of The Buyout Show examines the rapid consolidation of veterinary diagnostic laboratories by private equity. Lucas and Luna break down the economics: full-service labs like IDEXX and Antech dominate, but PE-backed platforms like Ethos Diagnostics and VCA's recent lab acquisitions are targeting regional and reference labs. They discuss why diagnostics are a sticky, high-margin business — consistent recurring revenue from sample testing, low customer churn, and integration with practice management software. The hosts walk through a typical roll-up strategy: acquire a regional lab, centralize processing, cut overhead, and expand the test menu. They also touch on regulatory risks, including the FTC's scrutiny of lab consolidation, and the impact on independent veterinarians who may face higher prices or longer turnaround times. Specific numbers: the U.S. veterinary diagnostics market is valued at $4.2 billion in 2026, growing at 8% CAGR, with PE-backed platforms now controlling roughly 25% of reference lab volume. #VeterinaryDiagnostics #PrivateEquity #RollUps #LabConsolidation #IDEXX #Antech #EthosDiagnostics #VCA #BusinessAcquisition #HealthcarePE #PetCare #Veterinary #DiagnosticTesting #FTC #MarketConsolidation #BusinessPodcast #FexingoBusiness #TheBuyoutShow Keep every episode free: buymeacoffee.com/fexingo